2020
$7.2M
from 3 investors over 3 rounds
AffyXell Therapeutics, Co., Ltd. raised undisclosed on April 13, 2022
Investors: Avacta Analytical
AffyXell Therapeutics, Co., Ltd. raised $7.2M on February 1, 2021
Investors: Smilegate Investment and Samsung Venture Investment